Biotech drug Simponi approved for arthritis in Canada

04/13/2009 | Reuters

Canadian drug regulators approved biologic drug Simponi to treat moderate to severe rheumatoid arthritis and active psoriatic arthritis. Simponi, a product of Johnson & Johnson and Schering-Plough, is awaiting regulatory clearance in the U.S. and Europe.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR